Um Estudo sobre o Tempo de Trânsito Gastrointestinal ao Nível da População (GITTPop)
Tempo de Trânsito Gastrointestinal ao Nível Populacional: Um Estudo Transversal
The goal of this study is to investigate the baseline of gastrointestinal transit time (GITT) and explore its relationship with other health indicators in 932 healthy adult volunteers.
The main questions it aims to answer are:
What are the population-level baseline values for GITT using the blue dye method? How is GITT associated with key physiological parameters including blood metabolic markers, life style, and stool characteristics?
Participants will:
Consume a standardized blue dye muffin after overnight fasting at the research center; Offer a finger prock blood samples for metabolic profiling; Offer a saliva sample for whole exome sequencing analysis; Collect stool samples for moisture measurement; Complete detailed questionnaires on diet, lifestyle, and bowel habits; Record the time of first blue stool appearance to determine GITT.
Visão geral do estudo
Status
Status
Condições
Condições
Intervenção / Tratamento
Intervenção / Tratamento
Descrição detalhada
This explorative study is designed as a cross-sectional investigation aimed at establishing population-level reference values for gastrointestinal transit time (GITT). Adult participants from the general population will undergo GITT measurement using the blue-dye method. This muffin contains blue colorant that cannot be absorbed; after ingestion, it passes through the entire gastrointestinal tract and is eventually excreted in feces. Following a two-day lifestyle standardization period (including dietary and activity guidance) to minimize potential confounding effects on gastrointestinal motility, participants will attend a clinical visit where they will ingest a blue muffin. GITT will be determined by measuring both the time interval between ingestion of the blue muffin and the first appearance of blue-colored stool, and the duration from its first appearance to its complete disappearance.
The blue muffin method has been well-established in previous research for GITT assessment. Building upon the methodology developed by Berry et al., we will introduce stricter pre-test condition controls (includes dietary advice and lifestyle recommendations) and optimized the blue muffin formulation. These improvements allow for reliable measurement with a single muffin administration, which has been evaluated through KU Leuven Health Pass in a large sample size(S-70168).
To investigate potential determinants and correlates of GITT, we will collect biochemical parameters, fecal moisture, and resting metabolic rate. We will collect saliva samples for WGS to identify key genetic variants associated with GITT and use these findings to develop a genetic risk score. Additionally, participants will complete 24-h diet record and health questionnaires assessing bowel movement, physical activity habits, stress levels, sleep quality and hydration condition for subsequent correlation analyses.
Tipo de estudo
Tipo de estudo
Inscrição (Estimado)
Inscrição
Contactos e Locais
Contato de estudo
Contato de estudo
- Nome: Christophe Matthys
- Número de telefone: +32 016342655
- E-mail: christophe.matthys@uzleuven.be
Estude backup de contato
- Nome: Wei Li
- Número de telefone: +32 016344539
- E-mail: wei.li2@kuleuven.be
Locais de estudo
-
-
Flemish Brabant
-
Leuven, Flemish Brabant, Bélgica, 3000
- Recrutamento
- Department of Chronic Diseases and Metabolism
-
Contato:
- Wim Janssens
- Número de telefone: +32 016252111
- E-mail: wim.janssens@kuleuven.be
-
Contato:
- Evelyne van Etten
- Número de telefone: +32 016330855
- E-mail: evelyne.vanetten@kuleuven.be
-
-
Critérios de participação
Critérios de elegibilidade
Critérios de elegibilidade
Idades elegíveis para estudo
Aceita Voluntários Saudáveis
Gêneros Elegíveis para o Estudo
Método de amostragem
População do estudo
Healthy volunteers from the Flanders region who volunteered to participate in the research
Descrição
Inclusion Criteria:
- 18-65 years old
- 18.5 kg/m² ≤ BMI ≤ 25 kg/m² or BMI ≥ 30 kg/m² (people with normal weight or obesity)
- Provision of informed consent to participate.
Exclusion Criteria:
- Gastrointestinal conditions which may affect nutrient absorption or gastric emptying, including coeliac disease, Crohn's disease, previous resection of the small intestine other than bariatric surgery, gastroparesis;
- Using medications which effect gastric motility (e.g., domperidone, erythromycin, metoclopramide, prucalopride, opiates, loperamide, …)
- The ingredients of blue muffins include gluten, nuts, baking powder, sugar, vanilla extract and sunflower oil. Participants with allergies to these ingredients;
- Current diagnosis of cancer;
- Advanced organ failure, including chronic kidney disease Stage 5, liver cirrhosis Child-Pugh B or C, intestinal failure, heart failure stage D, or chronic obstructive pulmonary disease stage 4;
- Immobility;
- Neuromuscular degenerative conditions associated with muscular atrophy, such as myasthenia gravis, muscular dystrophies, fibromyalgia, or multiple Sclerosis;
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Modelos de observação: COHORT
- Perspectivas de Tempo: CROSS_SECTIONAL
Número de grupos/coortes
Coortes e Intervenções
Grupo / CoorteGrupo / Coorte |
Intervenção / TratamentoIntervenção / Tratamento |
|---|---|
|
Adult participants
Healthy adult participants without serious gastrointestinal diseases |
Participants will consume a regular muffin containing blue dye |
O que o estudo está medindo?
Medidas de resultados primários
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Gastrointestinal transit time
Prazo: From enrollment to the end of study at 2 weeks
|
Calculate the transit time by the recorded muffin consuming time, first blue stool appearance time and last blue stool appearance time |
From enrollment to the end of study at 2 weeks
|
Medidas de resultados secundários
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Height (cm)
Prazo: baseline
|
Measured using a height meter, in centimeters. |
baseline
|
|
Weight (kg)
Prazo: baseline
|
Measuring using a scale, in kg. |
baseline
|
|
BMI
Prazo: baseline
|
weight and height will be combined to report BMI in kg/m^2 |
baseline
|
|
Blood glucose (mmol/L)
Prazo: baseline
|
Measure blood glucose by CardioChek Plus in mmol/L |
baseline
|
|
Fat mass (kg)
Prazo: baseline
|
Using Bodystat quadscan 4000 to measure fat mass (kg) |
baseline
|
|
Lean body mass(kg)
Prazo: baseline
|
Using Bodystat quadscan 4000 to measure lean body mass (kg) |
baseline
|
|
Fat percentage (%)
Prazo: baseline
|
Using Bodystat quadscan 4000 to measure fat% |
baseline
|
|
Total cholesterol (mmol/L)
Prazo: baseline
|
Measuring by Mission cholesterol Meter in mmol/L |
baseline
|
|
HDL-C (mmol/L)
Prazo: baseline
|
Measuring by Mission cholesterol Meter in mmol/L |
baseline
|
|
LDL-C (mmol/L)
Prazo: baseline
|
Measuring by Mission cholesterol Meter in mmol/L |
baseline
|
|
Triglyceride (mmol/L)
Prazo: baseline
|
Measuring by Mission Cholesterol Meter in mmol/L |
baseline
|
|
Food record
Prazo: 2 days after study
|
Participants record their 24-h diets through smartphone application |
2 days after study
|
|
Stool form
Prazo: baseline
|
Stool form will be evaluated by Bristol Stool Form Scale, the score is from 1 to 7, with values closer to the middle indicating more ideal stool shape. |
baseline
|
|
Hydration status
Prazo: baseline
|
Hydration status will be rated from 1 to 8 by Urine color chart, with higher numbers indicating that the body needs more water. |
baseline
|
|
Perceived level of stress
Prazo: baseline
|
The10-item Perceived Stress will be used to measures an individual's perceived level of stress over the past month. The total score ranges from 0 to 40. A higher score indicates a greater perceived level of stress. |
baseline
|
|
Sleep quality
Prazo: baseline
|
Pittsburgh Sleep Quality Index will be used to assess subjective sleep quality over the past month. The total score ranges from 0 to 21. A higher score indicates poorer sleep quality. |
baseline
|
|
Activity level
Prazo: baseline
|
The Baecke Physical Activity Questionnaire will be used to assess daily habitual physical activity, with a particular focus on work-related and exercise-related activities. It does not produce a single total score, but rather scores on three dimensions, each typically ranging from 1 to 5. On each dimension, a higher score indicates a higher level of physical activity in that area. Therefore, for assessing activity levels, a higher score is generally better. |
baseline
|
|
Whole genome sequencing (WGS)
Prazo: baseline
|
The genetic risk score will be calculated by summing the number of GITT-associated alleles carried by each participant, weighted by their estimated effect sizes. As the number and weights of the included variants will be determined during the analysis, the score does not have a predefined numerical range. The score will be standardized to a mean of 0 and a standard deviation of 1. A higher score will indicate a stronger genetic predisposition to the GITT phenotype of interest; it does not necessarily represent a better or worse health outcome. |
baseline
|
Colaboradores e Investigadores
Patrocinador
Patrocinador
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Real)
Início do estudo
Conclusão Primária (Estimado)
Conclusão Primária
Conclusão do estudo (Estimado)
Conclusão do estudo
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Primeira postagem
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última Atualização Postada
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Última verificação
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
Outros números de identificação do estudo
- S70908
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .